You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Chronic Myeloid Leukemia (CML) in lymphoid blast crisis

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Myeloid Leukemia in Myeloid Blast Crisis, Chronic Myeloid Leukaemia Transformation, Chronic Myeloid Leukemia -

Recruiting
  • Chronic Myeloid Leukemia in Myeloid Blast Crisis
  • +3 more
  • based decitabine and olverembatinib（HQP1351)chemotherapy
  • Guanzhou, China
    Department of Hematology, Nanfang Hospital, Southern Medical Uni
Dec 6, 2022

B-cell Acute Lymphoblastic Leukemia, Chronic Myeloid Leukemia (CML) in Lymphoid Blast Crisis, Philadelphia Chromosome Positive

Recruiting
  • B-cell Acute Lymphoblastic Leukemia
  • +2 more
  • Chicago, Illinois
  • +5 more
Dec 27, 2021

B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive,

Completed
  • B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Mar 25, 2022

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous

Recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 31, 2022

Acute Myeloid Leukemia, Acute Lymphoid Leukemia, Mixed Phenotype Acute Leukemia Trial in Gainesville (Orca-Q)

Recruiting
  • Acute Myeloid Leukemia
  • +6 more
  • Orca-Q
  • Gainesville, Florida
    University of Florida
Aug 26, 2022

Asciminib RMP Study

Not yet recruiting
  • Chronic Myeloid Leukemia
  • Asciminib
  • (no location specified)
Jul 5, 2023

Acute Biphenotypic Leukemia, Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial in

Recruiting
  • Acute Biphenotypic Leukemia
  • +13 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 19, 2023

Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Philadelphia Chromosome Positive, Recurrent Acute Lymphoblastic

Active, not recruiting
  • Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 2, 2022

Chronic Myeloid Leukemia (CML) Trial in France

Recruiting
  • Chronic Myeloid Leukemia (CML)
    • Annecy, France
    • +11 more
    Jul 18, 2023

    CALLS: CML and Ph+ALL Low Level Mutation Prevalence Survey

    Completed
    • Chronic Phase Chronic Myelogenous Leukemia
    • +3 more
      • Limerick, Dooradoyle, Ireland
      • +32 more
      Aug 13, 2021

      MDS, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic Trial in Newcastle (Subcutaneous azacitidine, Oral

      Not yet recruiting
      • Myelodysplastic Syndromes
      • +3 more
      • Subcutaneous azacitidine
      • Oral decitabine/cedazuridine
      • Newcastle, New South Wales, Australia
        Calvary Mater Newcastle
      May 29, 2023

      Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive,

      Completed
      • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
      • +4 more
      • Eltrombopag Olamine
      • Houston, Texas
        M D Anderson Cancer Center
      Jan 4, 2022

      Tyrosine Kinase Inhibitors, Chronic Myeloid Leukemia Trial in Poitiers (treatment of TKI in CML)

      Not yet recruiting
      • Tyrosine Kinase Inhibitors
      • Chronic Myeloid Leukemia
      • treatment of TKI in CML
      • Poitiers, France
        Chu Poitiers
      Feb 21, 2023

      CML, Chronic Phase, CML, Accelerated Phase Trial in Wuhan (HS-10382(Part 1: Dose escalation), HS-10382(Part 2: Dose expansion))

      Recruiting
      • CML, Chronic Phase
      • CML, Accelerated Phase
      • HS-10382(Part 1: Dose escalation)
      • HS-10382(Part 2: Dose expansion)
      • Wuhan, Hubei, China
        Union Hospital affiliated to Tongji Medical College of Huazhong
      Jan 12, 2023

      According to Molecular Identification at Diagnosis

      Not yet recruiting
      • Chronic Myeloid Leukemia
      • Next Generation Sequencing (DNA and RNA)
      • (no location specified)
      Oct 28, 2022

      Ponatinib in CML Patients in Chronic Phase

      Recruiting
      • Chronic Myeloid Leukemia, Chronic Phase
      • Therapeutic drug monitoring
      • Molecular Response
      • Cagliari, Italy
      • +4 more
      Nov 3, 2023

      Myelodysplastic Syndrome RAEB-I or RAEB-II, Refractory Acute Myeloid Leukemia, Refractory CML Myeloid Blast Crisis Trial in

      Completed
      • Myelodysplastic Syndrome RAEB-I or RAEB-II
      • +2 more
      • GM-CSF secreting leukemia vaccine
      • Boston, Massachusetts
        Dana-Farber Cancer Institute
      Jan 28, 2022

      Drug/Agent Toxicity by Tissue/Organ, Leukemia, MDS Trial in Chicago, Kankakee (amifostine trihydrate, cytarabine, mitoxantrone

      Withdrawn
      • Drug/Agent Toxicity by Tissue/Organ
      • +3 more
      • amifostine trihydrate
      • +2 more
      • Chicago, Illinois
      • +3 more
      Jan 31, 2023

      CML Trial in Ciudad Autonoma de Buenos Aire (Discontinuing treatment with Tyrosine Kinase Inhibitor after enrolment)

      Recruiting
      • CML
      • Discontinuing treatment with Tyrosine Kinase Inhibitor after enrolment
      • Ciudad Autonoma de Buenos Aire, Ciudad Autonoma De Buenos Aires, Argentina
        FUNDALEU
      Jun 29, 2023

      Condition Vasoregulation Function Endothelium in CML Getting TKI

      Recruiting
      • Chronic Myeloid Leukaemia
      • taking blood for the study of biochemical parameters and the study of microcirculation using the method of laser Doppler flowmetry
      • Moscow, Russian Federation
      • +1 more
      Jan 11, 2023

      Metabolic Alternation and Clinicohematological Characteristic in

      Not yet recruiting
      • CML, Chronic Phase
      • Tyrosine kinase inhibitor
      • (no location specified)
      Nov 6, 2023

      Concomitant Medications at CML Diagnosis

      Completed
      • Chronic Myeloid Leukemia
      • the prevalence of comorbid conditions
      • (no location specified)
      Sep 16, 2023

      Philadelphia Chromosome, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in Suzhou (Azacitidine, Venetoclax,

      Recruiting
      • Philadelphia Chromosome
      • +4 more
      • Suzhou, Jiangsu, China
        The First Affiliated Hospital of Soochow University
      Jun 23, 2022

      CML (Chronic Myelogenous Leukemia Trial (KDS-1001)

      Not yet recruiting
      • CML (Chronic Myelogenous Leukemia
      • (no location specified)
      Jul 27, 2022

      Chronic Myeloid Leukemia, Chronic Phase, Adult CML, Leukemia, Myeloid Trial in Augusta, Milwaukee (Asciminib, Ascimininb +

      Recruiting
      • Chronic Myeloid Leukemia, Chronic Phase
      • +3 more
      • Augusta, Georgia
      • +1 more
      Jul 14, 2022